(57)< Abstract > This invention is the formulation which adaptation is converted (a) dosage of the parathyroid hormone which almost from 6 covers the period of 24 months, and (b) in regard to the dosage of the bone absorption restrainer which almost from 12 after the dosage ending of the parathyroid hormone covers the period of 36 months, it regards the parathyroid hormone and the compound die pharmacy formulation which includes the bone absorption restrainer.本発明は、(a)ほぼ6から24カ月の期間にわたる副甲状腺ホルモンの投与、および(b)副甲状腺ホルモンの投与終了後のほぼ12から36カ月の期間にわたる骨吸収抑制剤の投与に関して適合化された製剤である、副甲状腺ホルモンおよび骨吸収抑制剤を含む複合型薬学的製剤に関する。